- 2026-12-04
-
17:55-19:00
Room 502
Video Session
Moderator
- 2026-12-06
-
Final outcomes of dalpiciclib and nonsteroidal aromatase inhibitors (NSAIs) in estrogen receptor-positive (ER+) recurrent/metastatic (R/M) ovarian cancer and uterine neoplasms.
08:14-08:21
Room 502
Mini Oral
Speaker


